Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Lumisight (pegulicianine) Optical Imaging Agent to Illuminate Residual Breast Cancer Post-Lumpectomy

(BUSINESS WIRE) April 18, 2024 --Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for...

FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara

(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...

Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome

Cutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease. Xiang...

Risk for Adverse Outcomes Increased With Antipsychotic Use in Dementia

For adults with dementia, antipsychotic use is associated with increased risks for stroke, venous thromboembolism, myocardial infarction, heart failure,...

Hoping to Conceive? Experts Offer Tips to Better Female Fertility

Women hoping to get pregnant sometimes wonder if there’s anything they can do to make it easier to conceive. Those questions might take on an added...

Inpatient Rehab Program Aids Adaptation to Epilepsy Diagnosis

An inpatient, epilepsy-related rehabilitation program shows lasting effects on several aspects of adaptation to epilepsy and quality of life, according...

Gains in Heart Health Only Experienced by Higher-Income Populations

Only higher-income populations experienced improvements in cardiovascular health from 1988 to 2018, according to a study published online April 3 in Circulation:...

Stigma, Shame Hit Many Gay Men Affected by Mpox Outbreak

A British study finds that beyond the physical pain and turmoil of an mpox diagnosis, many of the mostly gay and bisexual men infected during the 2022...

Calories, Not Meal Timing, Key to Weight Loss: Study

A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories -- with one group following a fasting schedule and the other...

Dietary Changes May Beat Meds in Treating IBS

The right diet may be the best medicine for easing the painful symptoms of irritable bowel syndrome (IBS), new research shows. In the study, two different...

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...

NIH Researchers Develop AI Tool with Potential to More Precisely Match Cancer Drugs to Patients

In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses data...

Walking Your Way to Better Health

Walking is one of the best exercises available to average folks, and it can be as easy as stepping out your front door, experts say. “It is something...

Counterfeit Versions of Botox Found in Multiple States

 FDA is alerting health care professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states...

Read more news...

Recently Added

Recently added consumer and prescribing information: Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Lumisight Lumisight (pegulicianine) is an optical imaging agent for the detection of residual cancerous tissue during breast cancer surgery.
  • Selarsdi Selarsdi (ustekinumab-aekn) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
  • Zevtera Zevtera (ceftobiprole medocaril) is a cephalosporin antibiotic for the treatment of bacteremia, acute bacterial skin and skin structure...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development